Your browser doesn't support javascript.
loading
The role of MRCP for preventing pancreatic fluid collection recurrence after EUS-guided drainage of walled-off necrosis.
Bofill, Aliana; Law, Ryan; Storm, Andrew C; Vargas, Eric J; Martin, John A; Petersen, Bret T; Majumder, Shounak; Vege, Santhi; Abu Dayyeh, Barham K; Chandrasekhara, Vinay.
Afiliação
  • Bofill A; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Law R; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Storm AC; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Vargas EJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Martin JA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Petersen BT; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Majumder S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Vege S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Abu Dayyeh BK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chandrasekhara V; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Chandrasekhara.Vinay@mayo.edu.
Gastrointest Endosc ; 2024 Jul 23.
Article em En | MEDLINE | ID: mdl-39053654
ABSTRACT
BACKGROUND AND

AIMS:

Pancreatic fluid collections (PFCs) may recur after initial successful endoscopic drainage of walled-off necrosis (WON), most commonly due to disconnected pancreatic duct syndrome (DPDS). The primary aim of this study was to assess the role of MRCP for identifying DPDS to guide appropriate management and prevent PFC recurrence.

METHODS:

Patients with WON undergoing lumen-apposing metal stent drainage of a PFC were retrospectively identified and categorized as those with MRCP versus those without MRCP before removal of transmural stents. Data on patient demographic characteristics, procedural details, cross-sectional imaging, and recurrence rates were collected through chart review.

RESULTS:

A total of 121 patients with WON were identified, of whom 44 (36.4%) had an MRCP before transmural stent removal. In patients without MRCP, 13 (16.8%) of 77 had PFC recurrence versus 0 of 44 (0%; P = .003) in those with MRCP. MRCP identified DPDS in 12 (27.2%) patients, all of whom were managed with indefinite drainage with double-pigtail plastic stents without recurrence. In the group without MRCP, PFCs recurred at a median interval of 284 days (interquartile range, 182-618 days) after transmural stent removal. Among the 13 patients with PFC recurrence, 11 (85%) had undiagnosed DPDS detected on subsequent imaging, of whom 9 were subsequently managed with indefinite double-pigtail plastic stents, with no further PFC recurrence.

CONCLUSIONS:

Patients with WON who underwent MRCP before transmural stent removal had a lower rate of PFC recurrence largely due to the identification of DPDS with appropriate endoscopic management.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article